+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?



Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?



Risk Management and Healthcare Policy 3: 1-11



Cardiovascular disease remains the leading cause of death in the world. A significant amount of clinical data are available to demonstrate the positive influence that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy has on slowing the progression of cardiovascular disease and improving clinical outcomes. Achieving the treatment goals for cholesterol in cardiovascular disease continues to present challenges. Recent clinical trial information is available assessing the use of more aggressive initial doses of statin therapy based on initial low-density lipoprotein cholesterol (LDL-C) measurements in an attempt to reach treatment goals sooner. Six clinical trials assessed low-, moderate- and high-risk individuals as well as those with type 2 diabetes mellitus to determine if this treatment approach is both safe and effective. The studies concluded that initial dosing of statin therapy determined by a baseline LDL-C measurement demonstrates good achievement in reaching treatment goals and does not result in a higher rate of adverse effects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053817175

Download citation: RISBibTeXText

PMID: 22312212

DOI: 10.2147/RMHP.S7376


Related references

Geriatric Anesthesia: Can We Achieve the Goal of Returning our Elderly to Baseline or Improved Function?. Anesthesiology Clinics 33(3): Xiii-Xxiv, 2016

Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis. Atherosclerosis 237(2): 829-837, 2015

Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy. Clinical Drug Investigation 27(5): 333-337, 2007

Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency. Therapeutics and Clinical Risk Management 11(): 127-136, 2015

RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale. Lipids in Health and Disease 12(): 142-142, 2014

Impact of Adding Ezetimibe to Statin to Achieve Low-Density Lipoprotein Cholesterol Goal from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation COURAGE Trial. 2013

Impact of adding ezetimibe to statin to achieve low-density lipoprotein cholesterol goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] trial). American Journal of Cardiology 111(11): 1557-1562, 2013

When is enough enough? Individualized goal-directed fluid therapy for surgery. Journal of Clinical Monitoring and Computing 27(3): 223-224, 2014

Therapy refractory pain. How to still achieve your goal. Mmw Fortschritte der Medizin 142(17): 4-8, 2000

Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial. Mayo Clinic Proceedings 81(9): 1177-1185, 2006

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease. Circulation 133(16): 1574-1581, 2016

Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?. American Journal of Cardiovascular Drugs 14(2): 79-87, 2014

Is atherosclerosis regression a realistic goal of statin therapy and what does that mean?. Current Atherosclerosis Reports 15(1): 294-294, 2013

Effect of individualized goal directed therapy on outcome after major sugery. Masui. Japanese Journal of Anesthesiology 61(10): 1071-1076, 2013

Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 20: 15-15, 2012